First-in-Human Study of SCB0020160 by SCBIO Inc. Underway
SCBIO Inc. is conducting a first-in-human trial for SCB0020160 to evaluate its safety and pharmacokinetics.
Asset / Drug
Drug and asset intelligence for SCB0020160 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.